135 related articles for article (PubMed ID: 6150994)
1. Biological markers in mental disorders: post-mortem studies.
Rossor M
J Psychiatr Res; 1984; 18(4):457-65. PubMed ID: 6150994
[TBL] [Abstract][Full Text] [Related]
2. No evidence for lateral asymmetry of neurotransmitters in post-mortem human brain.
Rossor M; Garrett N; Iversen L
J Neurochem; 1980 Sep; 35(3):743-5. PubMed ID: 6108998
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine receptors in Alzheimer-type dementia.
Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Markakis D
Neurosci Lett; 1984 Nov; 52(1-2):1-6. PubMed ID: 6241300
[TBL] [Abstract][Full Text] [Related]
4. Significance of neurotransmitter abnormalities in Alzheimer's disease.
Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
[No Abstract] [Full Text] [Related]
5. Chemical and structural changes in the brain in patients with movement disorder.
Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Johnstone EC; Owen F; Owens DG; Poulter M
Psychopharmacology Suppl; 1985; 2():104-10. PubMed ID: 2860653
[TBL] [Abstract][Full Text] [Related]
6. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.
Spokes EG
Brain; 1979 Jun; 102(2):333-46. PubMed ID: 455043
[TBL] [Abstract][Full Text] [Related]
7. Post-mortem neurochemical changes in Alzheimer's disease compared with normal ageing.
Rossor M; Mountjoy CQ
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):499-502. PubMed ID: 2878713
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients.
Korpi ER; Kleinman JE; Goodman SI; Wyatt RJ
Psychiatry Res; 1987 Dec; 22(4):291-301. PubMed ID: 2893404
[TBL] [Abstract][Full Text] [Related]
9. Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain.
Hörtnagl H; Pifl C; Hörtnagl E; Reiner A; Sperk G
J Neurochem; 2020 Mar; 152(6):650-662. PubMed ID: 31608979
[TBL] [Abstract][Full Text] [Related]
10. [Distributions and functions of neurotransmitters and their related enzymes in individual brain nuclei].
Uchimura H; Hirano M; Matsumoto T; Nakahara T; Itoh M; Oomagari K
Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1353-63. PubMed ID: 6152064
[No Abstract] [Full Text] [Related]
11. Postmortem neurochemistry in schizophrenia.
Bracha HS; Kleinman JE
Psychiatr Clin North Am; 1986 Mar; 9(1):133-41. PubMed ID: 2421270
[TBL] [Abstract][Full Text] [Related]
12. Progressive supranuclear palsy: postmortem chemical analysis.
Young AB
Ann Neurol; 1985 Nov; 18(5):521-2. PubMed ID: 2866753
[No Abstract] [Full Text] [Related]
13. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type.
Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994
[No Abstract] [Full Text] [Related]
15. [Brain of patients with chronic schizophrenia and neurotransmitters].
Toru M
Seishin Shinkeigaku Zasshi; 2005; 107(10):1015-21. PubMed ID: 16381382
[No Abstract] [Full Text] [Related]
16. Dopamine metabolism increases in post-mortem schizophrenic basal ganglia.
Toru M; Nishikawa T; Mataga N; Takashima M
J Neural Transm; 1982; 54(3-4):181-91. PubMed ID: 6127373
[TBL] [Abstract][Full Text] [Related]
17. Lateral asymmetry of neurotransmitters in human brain.
Glick SD; Ross DA; Hough LB
Brain Res; 1982 Feb; 234(1):53-63. PubMed ID: 6120746
[TBL] [Abstract][Full Text] [Related]
18. Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction.
Kanazawa I; Kwak S; Sasaki H; Muramoto O; Mizutani T; Hori A; Nukina N
J Neurol Sci; 1988 Jan; 83(1):63-74. PubMed ID: 2450180
[TBL] [Abstract][Full Text] [Related]
19. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
20. The cholinergic system in old age and Alzheimer's disease.
Perry EK
Age Ageing; 1980 Feb; 9(1):1-8. PubMed ID: 7361631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
